Tasigna is a medication used in the treatment of a type of cancer called Ph+ Chronic Myeloid Leukemia (PH+CML) which forms in bone marrow and causes an accumulation of white blood cells that can travel to other parts of the body. Tasigna works by blocking the proteins that cancer cells need to grow and spread, without affecting non-cancerous cells. However, patients who were treated with the drug are complaining of serious injuries including the development of a rapidly-progressing, irreversible deadly condition that may lead to stroke, heart attack, amputations, gangrene and death, and some are speaking with a Tasigna lawyer about seeking justice and compensation.

Tasigna Associated with Hardened Arteries

Atherosclerosis, commonly called hardened arteries, is a serious condition in which your arteries become hard and thick with plaque. As plaque builds, the amount of blood that can travel through them is reduced. This means atherosclerosis can reduce blood flow to critical organs, such as the heart and the brain, and to the extremities.

Hardened arteries can lead to other serious conditions including:

• Carotid artery disease
• Coronary artery disease
• Peripheral artery disease

And like a dangerous ripple effect, those conditions can lead to dangerous and potentially fatal consequences like:

• Blocked arteries
• Amputations
• Heart attack
• Stroke
• Severe infections
• Serious cardiovascular issues
• Gangrene

Patients Are Demanding Answers

Leukemia patients who developed rapidly progressing, irreversible hardened arteries say they were never warned about the increased risks of atherosclerosis and related potentially life-threatening consequences. Yet Novartis, the maker of Tasigna did issue warnings to doctors and patients in some countries, including Canada. Novartis issued alerts, physician reference documents, information brochures for patients, and posted this information on the Novartis Canada website and the Health Canada website.

Patients in the U.S. want to know why Novartis failed to provide them and their physicians the information that would have helped them make informed medical decisions, such as whether the benefits of the drug outweigh its potentially fatal side effects. And they want to know when Novartis knew or should have known the drug could cause hardened arteries and how long they hid those risks.

Lawsuits Filed on Behalf of Tasigna Patients

Patients who were diagnosed with arteriosclerosis after receiving Tasigna treatment are seeking justice and redress for their Tasigna related injuries and losses. In fact, lawsuits are being filed on behalf of Tasigna patients across the nation and on behalf of the families of those who suffered fatal complications like heart attack and stroke.

If you or a Ph+CML patient you love received Tasigna and developed rapid hardening of the arteries, you may be eligible to hold Novartis accountable for failing to warn them of the increased dangers that have been associated with the drug. We have been helping patients get the justice they deserve and the compensation they need for injuries caused by dangerous medicines and products for decades, and we can help you too. Contact us today to learn more about Tasigna, its side effects and whether you are entitled to significant financial compensation for your injuries.